Macquarie Group’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Sell |
94,632
-1,151
| -1% | -$26.5K | ﹤0.01% | 1197 |
|
|
2025
Q1 | $2.15M | Sell |
95,783
-2,214
| -2% | -$49.7K | ﹤0.01% | 1195 |
|
|
2024
Q4 | $1.92M | Sell |
97,997
-1,264
| -1% | -$24.7K | ﹤0.01% | 1209 |
|
|
2024
Q3 | $1.81M | Buy |
99,261
+267
| +0.3% | +$4.86K | ﹤0.01% | 1263 |
|
|
2024
Q2 | $1.72M | Buy |
98,994
+9,270
| +10% | +$161K | ﹤0.01% | 1273 |
|
|
2024
Q1 | $1.76M | Buy |
89,724
+13,650
| +18% | +$267K | ﹤0.01% | 1261 |
|
|
2023
Q4 | $1.75M | Buy |
76,074
+3,839
| +5% | +$88.4K | ﹤0.01% | 1258 |
|
|
2023
Q3 | $1.66M | Buy |
72,235
+13,701
| +23% | +$315K | ﹤0.01% | 1221 |
|
|
2023
Q2 | $1.53M | Sell |
58,534
-1,095,849
| -95% | -$28.6M | ﹤0.01% | 1260 |
|
|
2023
Q1 | $31.9M | Sell |
1,154,383
-167,334
| -13% | -$4.62M | 0.04% | 558 |
|
|
2022
Q4 | $30M | Buy |
1,321,717
+90,658
| +7% | +$2.06M | 0.04% | 606 |
|
|
2022
Q3 | $42M | Buy |
1,231,059
+431,706
| +54% | +$14.7M | 0.05% | 482 |
|
|
2022
Q2 | $23.3M | Buy |
799,353
+724,449
| +967% | +$21.1M | 0.03% | 676 |
|
|
2022
Q1 | $2K | Buy |
74,904
+2,385
| +3% | +$64 | ﹤0.01% | 1370 |
|
|
2021
Q4 | $1.88M | Buy |
72,519
+1,756
| +2% | +$45.4K | ﹤0.01% | 1391 |
|
|
2021
Q3 | $1.67M | Buy |
70,763
+17,155
| +32% | +$404K | ﹤0.01% | 1436 |
|
|
2021
Q2 | $2.38M | Buy |
+53,608
| New | +$2.38M | ﹤0.01% | 1362 |
|